Palvella Therapeutics Inc (PVLA)

$13.18 -0.04 (-0.30%)
Market Cap 17.45M
Revenue (ttm) 42.81M
Net Income (ttm) -24.54M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -57.32%
Debt to Equity Ratio 0.00
Volume 15,900
Avg Vol 37,674
Day's Range N/A - N/A
Shares Out 1.32M
Stochastic %K 32%
Beta 0.67
Analysts Strong Sell
Price Target $34.00

Latest News on PVLA

Palvella Therapeutics Announces Closing of Merger with Pieris Pharmaceuticals and Concurrent Private Placement of $78.9 Million

Dec 13, 2024, 2:55 PM EST - 5 weeks ago

Palvella Therapeutics Announces Closing of Merger with Pieris Pharmaceuticals and Concurrent Private Placement of $78.9 Million